Marken: Global Life Science Supply Chain Solutions | Recorded the 10-Oct-2018 | Webinar
Study protocols are increasingly complex with the need for extensive data collection despite complicated drug regimes. Patients may be deterred from taking...
Monitoring spatial product temperature variation is critical to process development and scale-up in the pharma/bio-pharmaceutical industry. While using...
EMD Millipore | Recorded the 13-Apr-2016 | Webinar
As many biologics will or have come off patent, the opportunity for competition, and potentially lower costs through biosimilars, is created. Barriers...
IMA: 50 years of innovation in processing and packaging machines | Recorded the 22-Apr-2016 | Webinar
The freeze drying community has dedicated resources for artificially inducing nucleation since it was introduced to the community as a means for reliable...
Merck KGaA, Darmstadt, Germany | Recorded the 09-Apr-2015 | Webinar
Pyrogens in pharmaceuticals, medical devices, biotherapeutics and cosmetics can cause fevers in humans and are potentially life-threatening. Yet standard...
Fujifilm Diosynth Biotechnologies | Recorded the 28-May-2014 | Webinar
The development of large scale E. coli expression systems can be rate limiting in process development. Fujifilm's pAVEway™ system combines innovative...
Fujifilm Diosynth Biotechnologies | Recorded the 10-Dec-2013 | Webinar
ADCs are showing great promise as a new therapeutic entity, but have a complex supply chain requiring biologics and high potency capability. This presentation...
ATMI Life Science | Recorded the 19-Sep-2013 | Webinar
Single-use bioprocessing technologies raise persistent concerns about integrity. Sterility of the bag must be maintained in order to avoid contamination...
ATMI Life Science | Recorded the 16-May-2013 | Webinar
The Integrity® LevMixer® single-use mixing system from ATMI LifeSciences is an innovative, low shear and low particulate mixing platform designed for manufacturing...
Piramal Healthcare Ltd | Recorded the 24-May-2013 | Webinar
With the recent approvals of brentuximab vedotin (Adcetris) and ado-trastuzumab emtansine (Kadcyla,T-DM1), antibody–drug conjugates (ADCs)are a rapidly...
